Search Within

Marc Ladanyi

  1. "Jose Baselga"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (9)
  3. Research Letter (2)
Groups
  1. Department of Medicine (26)
  2. Department of Pathology and Laboratory Medicine (26)
  3. GSK Faculty (26)
  4. Human Oncology and Pathogenesis Program (26)
  5. Solid Tumor Oncology Division (26)
  6. Tow Center for Developmental Oncology (TCDO) (26)

More Groups

People
  1. Jose Baselga (26)
  2. David Hyman (22)
  3. David Solit (22)
  4. Michael Berger (22)
  5. Ahmet Zehir (21)
  6. Maria Arcila (15)

More People

Years
  1. 2020 (1)
  2. 2019 (5)
  3. 2018 (3)
  4. 2017 (9)
  5. 2016 (4)
  6. 2015 (4)
Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer Discovery (3)
  3. Blood (2)
  4. Cancer Research (2)
  5. JCO Precision Oncology (2)
  6. Journal of Molecular Diagnostics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (5)
  3. Nature Publishing Group (4)
  4. American Medical Association (2)
  5. American Society of Hematology (2)
  6. Cell Press (2)

More Publishers

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • BRCA-mediated tumorigenesis is origin and cell-type dependent
    Meeting Abstract

    Jonsson, P.; Cheng, M. L.; Bandlamudi, C.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumour lineage shapes BRCA-mediated phenotypes
    Research Letter

    Jonsson, P.; Bandlamudi, C.; Cheng, M. L.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Next-generation sequencing–based assessment of JAK2, PD-L1, and PD-L2 copy number alterations at 9p24.1 in breast cancer: Potential implications for clinical management
    Journal Article

    Gupta, S.; Vanderbilt, C. M.; Cotzia, P.; Arias-Stella, J. A. 3rd; Chang, J. C.; Zehir, A.; Benayed, R.; Nafa, K.; Razavi, P.; Hyman, D. M.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Journal Article

    Latham, A.; Srinivasan, P.; Kemel, Y.; Shia, J.; Bandlamudi, C.; Mandelker, D.; Middha, S.; Hechtman, J.; Zehir, A.; Dubard-Gault, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Prevalence of clonal hematopoiesis mutations in tumor-only clinical genomic profiling of solid tumors
    Journal Article

    Ptashkin, R. N.; Mandelker, D. L.; Coombs, C. C.; Bolton, K.; Yelskaya, Z.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • The genomic landscape of endocrine-resistant advanced breast cancers
    Journal Article

    Razavi, P.; Chang, M. T.; Xu, G.; Bandlamudi, C.; Ross, D. S.; Vasan, N.; Cai, Y.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Accelerating discovery of functional mutant alleles in cancer
    Journal Article

    Chang, M. T.; Shrestha Bhattarai, T.; Schram, A. M.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; Chakravarty, D.; Phillips, S.; Kandoth, C.; Penson, A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma
    Journal Article

    Shukla, N.; Roberts, S. S.; Baki, M. O.; Mushtaq, Q.; Goss, P. E.; Park, B. H.; Gundem, G.; Tian, K.; Geiger, H.; Redfield, K.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save